CRMP4a suppresses cell motility by sequestering RhoA activity in prostate cancer cells

References

• Steeg PS. 2016. Targeting metastasis. Nat Rev Cancer. 16:201–218. doi:10.1038/nrc.2016.25.
   PubMed Web of Science ®Google Scholar
• Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17:302–317. doi:10.1038/nrc.2017.6.
   PubMed Web of Science ®Google Scholar
• Jansen S, Gosens R, Wieland T, Schmidt M. 2018. Paving the Rho in cancer metastasis: rho GTPases and beyond. Pharmacol Ther. 183:1–21. doi:10.1016/j.pharmthera.2017.09.002.
   PubMed Web of Science ®Google Scholar
• Nagai J, Baba R, Ohshima T. 2017. CRMPs Function in Neurons and Glial Cells: potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury. Mol Neurobiol. 54:4243–4256. doi:10.1007/s12035-016-0005-1.
   PubMed Web of Science ®Google Scholar
• Rosslenbroich V, Dai L, Baader SL, Noegel AA, Gieselmann V, Kappler J. 2005. Collapsin response mediator protein-4 regulates F-actin bundling. Exp Cell Res. 310:434–444. doi:10.1016/j.yexcr.2005.08.005.
   PubMed Web of Science ®Google Scholar
• Alabed YZ, Pool M, Ong Tone S, Fournier AE. 2007. Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition. J Neurosci. 27:1702–1711. doi:10.1523/JNEUROSCI.5055-06.2007.
   PubMed Web of Science ®Google Scholar
• Tan F, Thiele CJ, Li Z. 2014. Collapsin response mediator proteins: potential diagnostic and prognostic biomarkers in cancers (Review). Oncol Lett. 7:1333–1340. doi:10.3892/ol.2014.1909.
   PubMed Web of Science ®Google Scholar
• Gao X, Pang J, Li LY, Liu WP, Di JM, Sun QP, Fang YQ, Liu XP, Pu XY, He D, et al. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene. 2010;29:4555–4566. doi:10.1038/onc.2010.213.
   PubMed Web of Science ®Google Scholar
• Li C, Jiang W, Hu Q, Li LC, Dong L, Chen R, Zhang Y, Tang Y, Thrasher JB, Liu CB, et al. Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis. Oncotarget. 2016;7:22893–22910. doi:10.18632/oncotarget.8290.
   PubMedGoogle Scholar
• Li K, Pang J, Cheng H, Liu WP, Di JM, Xiao HJ, Luo Y, Zhang H, Huang WT, Chen MK, et al. Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase. Oncotarget. 2015;6:10030–10044. doi:10.18632/oncotarget.3192.
   PubMedGoogle Scholar
• Zhou W, Xie P, Pang M, Yang B, Fang Y, Shu T, Liu C, Wang X, Zhang L, et al. Upregulation of CRMP4, a new prostate cancer metastasis suppressor gene, inhibits tumor growth in a nude mouse intratibial injection model. Int J Oncol. 2015;46:290–298. doi:10.3892/ijo.2014.2705.
   PubMed Web of Science ®Google Scholar
• Khazaei MR, Girouard MP, Alchini R, Ong Tone S, Shimada T, Bechstedt S, Cowan M, Guillet D, Wiseman PW, Brouhard G, et al. Collapsin response mediator protein 4 regulates growth cone dynamics through the actin and microtubule cytoskeleton. J Biol Chem. 2014;289:30133–30143. doi:10.1074/jbc.M114.570440.
   PubMed Web of Science ®Google Scholar
• Havel LS, Kline ER, Salgueiro AM, Marcus AI. 2015. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene. 34:1979–1990. doi:10.1038/onc.2014.123.
   PubMed Web of Science ®Google Scholar
• Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B. 2004. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology. 145:2941–2949. doi:10.1210/en.2003-1519.
   PubMed Web of Science ®Google Scholar
• Pellegrino L, Stebbing J, Braga VM, Frampton AE, Jacob J, Buluwela L, Jiao LR, Periyasamy M, Madsen CD, Caley MP, et al. miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res. 2013;41:5400–5412. doi:10.1093/nar/gkt245.
   PubMed Web of Science ®Google Scholar
• Steffen A, Stradal TE, Rottner K. 2017. Signalling Pathways Controlling Cellular Actin Organization. Handb Exp Pharmacol. 235:153–178. doi:10.1007/164_2016_35.
   PubMedGoogle Scholar
• Rottner K, Faix J, Bogdan S, Linder S, Kerkhoff E. 2017. Actin assembly mechanisms at a glance. J Cell Sci. 130:3427–3435. doi:10.1242/jcs.206433.
   PubMed Web of Science ®Google Scholar
• Narumiya S, Tanji M, Ishizaki T. 2009. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 28:65–76. doi:10.1007/s10555-008-9170-7.
   PubMed Web of Science ®Google Scholar
• Haga RB, Ridley AJ. 2016. Rho GTPases: regulation and roles in cancer cell biology. Small GTPases. 7:207–221. doi:10.1080/21541248.2016.1232583.
   PubMedGoogle Scholar
• Ridley AJ. 2015. Rho GTPase signalling in cell migration. Curr Opin Cell Biol. 36:103–112. doi:10.1016/j.ceb.2015.08.005.
   PubMed Web of Science ®Google Scholar
• Cuvelier D, Thery M, Chu YS, Dufour S, Thiery JP, Bornens M, Nassoy P, Mahadevan L. The universal dynamics of cell spreading. Curr Biol. 2007;17:694–699. doi:10.1016/j.cub.2007.02.058.
   PubMed Web of Science ®Google Scholar
• Gao X, Li LY, Rassler J, Pang J, Chen MK, Liu WP, Chen Z, Ren SC, Zhou FJ, Xie KJ, et al. Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node Metastases. J Natl Cancer Inst. 2017;109(6):djw282.
   Google Scholar
• Huang QX, Xiao CT, Chen Z, Lu MH, Pang J, Di JM, Luo ZH, Gao X. Combined analysis of CRMP4 methylation levels and CAPRA-S score predicts metastasis and outcomes in prostate cancer patients. Asian J Androl. 2018;20:56–61. doi:10.4103/aja.aja_3_17.
   PubMed Web of Science ®Google Scholar
• Gao X, Mao YH, Xiao C, Li K, Liu W, Li LY, Pang J. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-kappaB/DNMT1 signaling pathway. Prostate. 2018. doi:10.1002/pros.23512.
   Web of Science ®Google Scholar
• Yoneda A, Morgan-Fisher M, Wait R, Couchman JR, Wewer UM. 2012. A collapsin response mediator protein 2 isoform controls myosin II-mediated cell migration and matrix assembly by trapping ROCK II. Mol Cell Biol. 32:1788–1804. doi:10.1128/MCB.06235-11.
   PubMed Web of Science ®Google Scholar
• Leung T, Ng Y, Cheong A, Ng CH, Tan I, Hall C, Lim L. p80 ROKalpha binding protein is a novel splice variant of CRMP-1 which associates with CRMP-2 and modulates RhoA-induced neuronal morphology. FEBS Lett. 2002;532:445–449.
   PubMed Web of Science ®Google Scholar
• Morgan-Fisher M, Couchman JR, Yoneda A. 2013. Phosphorylation and mRNA splicing of collapsin response mediator protein-2 determine inhibition of rho-associated protein kinase (ROCK) II function in carcinoma cell migration and invasion. J Biol Chem. 288:31229–31240. doi:10.1074/jbc.M113.505602.
   PubMed Web of Science ®Google Scholar
• Arimura N, Inagaki N, Chihara K, Menager C, Nakamura N, Amano M, Iwamatsu A, Goshima Y, Kaibuchi K. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for Two Separate Signaling Pathways for Growth Cone Collapse. J Biol Chem. 2000;275:23973–23980.
   Google Scholar
• Arimura N, Menager C, Kawano Y, Yoshimura T, Kawabata S, Hattori A, Fukata Y, Amano M, Goshima Y, Inagaki M, et al. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol Cell Biol. 2005;25:9973–9984. doi:10.1128/MCB.25.22.9973-9984.2005.
   PubMed Web of Science ®Google Scholar